Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ACADIA Pharmaceuticals Inc. (ACAD) vs Williams Companies Inc (WMB) Price & Performance

ACADIA Pharmaceuticals Inc.Trade
Williams Companies IncTrade

Price performance (Past 24H)

Key statistics

ACADIA Pharmaceuticals Inc. vs Williams Companies Inc — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.52 (market cap $5.07B), while Williams Companies Inc trades at $71.97 (market cap $88.45B). The key difference: Williams Companies Inc is far larger — about 17.4× ACADIA Pharmaceuticals Inc.'s market cap, and Williams Companies Inc pays a 2.9% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.

ACADWMB
Market Cap
$5.07B$88.45B
Sector
HealthEnergy
52-Week High
$29.41$79.40
52-Week Low
$20.06$56.51
Enterprise Value
$4.19B$119.07B
Dividend Yield
2.9%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Read more on ACAD

About Williams Companies Inc

Williams is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.

Read more on WMB